Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

57294 Press Releases
DateTitleCompany
16 Apr 14 DaVita's Teammate-Focused Culture Gains National and Local Awards DAVITA,
Published by
PR Newswire
16 Apr 14 QIAGEN expands and upgrades Germantown facilities and consolidates Maryland sites into two campuses PR NEWSWIRE EUROPE,
Published by
PR Newswire
16 Apr 14 BioLife Solutions Announces Preliminary Q1 2014 Revenue of $2 Million BIOLIFE SOLUTIONS INC,
Published by
PR Newswire
16 Apr 14 RBCC Bioprinting Partner Expands Brand Awareness Campaign Rainbow Coral Corp.,
Published by
Business Wire
16 Apr 14 USFDA, MHRA and Lachman Consultants - All Under One Roof at CPhI's 3rd Annual Global Pharma Regulatory Summit 2014 UBM India,
Published by
PR Newswire
16 Apr 14 OxThera AB Receives SEK 70 Million Financing to Continue its Key Clinical Programs OxThera,
Published by
PR Newswire
16 Apr 14 Heptares at Upcoming Diabetes and Neuroscience Partnering and Investment Conferences Heptares Therapeutics,
Published by
PR Newswire
16 Apr 14 Dr. Reddy’s Announces the Launch of Eszopiclone Tablets C-IV Dr. Reddy’s Laboratories Ltd.,
Published by
Business Wire
15 Apr 14 Repligen Corporation Set to Join the S&P SmallCap 600 STANDARD & POORS,
Published by
PR Newswire
15 Apr 14 World’s Leading BioMag Experts Coming to Nova Scotia BioMag 2014,
Published by
Business Wire
15 Apr 14 Pacira Pharmaceuticals Announces Grants of Inducement Stock Options Under NASDAQ Listing Rule 5635(c)(4) Pacira Pharmaceuticals Inc.,
Published by
Business Wire
15 Apr 14 Cannabis-Rx Appoints Munjit S. Johal Treasurer & Chief Financial Officer Cannabis-Rx,
Published by
Business Wire
15 Apr 14 Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014 Gilead Sciences Inc.,
Published by
Business Wire
15 Apr 14 Eleven Biotherapeutics Announces Filing of its Annual Report on Form 10-K Eleven Biotherapeutics,
Published by
Business Wire
15 Apr 14 Adamas Pharmaceuticals Announces Closing of Its Initial Public Offering ADAMAS PHARMACEUTICALS,
Published by
PR Newswire
15 Apr 14 Endo to Announce First Quarter 2014 Financial Results on May 1, 2014 ENDO PHARMACEUTICALS INC.,
Published by
PR Newswire
15 Apr 14 Global Bioenergies Reports 2013 Financial Results Global Bioenergies,
Published by
Business Wire
15 Apr 14 Applied BioCode to Present Poster at CVS on Multiplex Gastrointestinal Pathogen Detection with a User Friendly, High Throughput System Applied BioCode,
Published by
Business Wire
15 Apr 14 Prominent Researchers Discuss Translating Basic Research into Therapies at UMass ‘Models to Medicine’ Symposium on May 2 UMass Amherst Institute of Applied Sciences,
Published by
Business Wire
15 Apr 14 Teva Announces Launch of Generic Lunesta® Tablets in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
15 Apr 14 Harvard Apparatus Regenerative Technology Collaborator Successfully Transplants Regenerated Esophagus into Rat Harvard Apparatus Regenerative Technology,
Published by
Business Wire
15 Apr 14 Stephen L. Holcombe Appointed President of TransTech Pharma and High Point Pharmaceuticals TransTech Pharma LLC,
Published by
Business Wire
15 Apr 14 Implanet Strengthens Its Board by Appointing an International Sectorial Expert IMPLANET,
Published by
Business Wire
15 Apr 14 CROMSOURCE Expands European Headquarters – Opens New Office Building CROMSOURCE,
Published by
PharmiWeb
15 Apr 14 Dr. Anil Kumar, MD, Files His Candidacy For United States Congress 11th District In Michigan MORT MEISNER ASSOCIATES,
Published by
PR Newswire
15 Apr 14 US Military Approves New Treatment for Troops to Save Lives on the Battlefield MedTrade Products Limited,
Published by
PR Newswire
15 Apr 14 Healthcare Providers Weigh In on InterSystems HealthShare in KLAS 2014 HIE Report InterSystems
15 Apr 14 Almac Receives New York State Laboratory Permit for Trial Enrichment and Companion Diagnostics Development Almac
15 Apr 14 Centice Announces the Release of Version 5.5 of its Drug Identification Software with Significant New Additions to the Illicit Database Centice Corporation,
Published by
Business Wire
15 Apr 14 Akebia Therapeutics Announces Completion of Enrollment in its Phase 2b Clinical Study of AKB-6548 Akebia Therapeutics Inc.,
Published by
Business Wire
Advertising